权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Research Core

研究核心

基本信息

批准号：
10403254
负责人：
Josh Baxter
金额：
$ 48.62万
依托单位：
UNIVERSITY OF PENNSYLVANIA
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-02-01 至 2027-12-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10403254
关键词：
Acceleration Acute Address Animal Experiments Animals Attenuated Biological Assay Caring Cells Center for Translational Science Activities Chemicals Chronic Clinical Clinical Research Clinical Trials Data Set Disease Disease Progression Dose Equity Exercise Funding Future Health Homeostasis Hospitals Human Inequity Injections Insurance Carriers Intuition Joints Link Mechanics Medicine Modeling Monitor Musculoskeletal Operative Surgical Procedures Outcome Pain Pathogenesis Patient Care Patient-Focused Outcomes Patients Physical therapy Population Pre-Clinical Model Protocols documentation Rattus Regimen Registries Reporting Research Research Personnel Research Project Grants Rural Community Sampling Science Techniques Tendinopathy Tendon Injuries Tendon structure Testing Therapeutic Agents Tissues Translating Translational Research Translations Ultrasonography United States National Institutes of Health Urban Community achilles tendon care delivery clinical translation clinically relevant cost early onset effectiveness testing follow-up fundamental research gait examination healing human tissue improved in vivo innovation mechanical load metabolomics new technology novel pain symptom patient population pre-clinical pre-clinical research preclinical study rehabilitative care research study suburban communities tendon rupture therapeutic effectiveness tool translation assay translational impact ultrasound

项目摘要

Research Core Summary Achilles tendinopathy is a painful, debilitating, and chronic tendon condition. Patients receive physical therapy as the first step in conservative treatment. These physical therapy protocols – which are the only non- surgical treatments paid for by most insurers – prescribe mechanical loads as a therapeutic agent. However, sixty percent of patients continue to report painful symptoms after 5 years, and fifty percent of patients seek surgical treatment after conservative treatment fails. Therefore, maximizing the therapeutic effectiveness of mechanical loading is critical towards improving patient outcomes and reducing the need for costly and often ineffective surgical treatments. To meet this unmet clinical need, our proposed Research Projects will establish the mechano-responsiveness of tendon cells throughout tendinopathy disease progression and elucidate the mechanotransductive mechanisms that regulate cell fate and tissue homeostasis to attenuate disease progression and improve tendon healing. To accelerate clinical translation, the overall objective of this Achilles Tendinopathy Tissue Core is to provide patient and clinically relevant rat tendon samples, ranging from healthy to degenerated, combined with the most complete set of longitudinal in vivo assays to maximize the translational impact of our Research Projects proposed in this P50 application, as well as numerous NIH funded projects at Penn aimed at improving tendon healing by our P50 team of investigators. In Aim 1, we will retrieve patient tissues to investigate end-stage Achilles tendinopathy mechano-sensitivity. In Aim 2, we will leverage a tendinopathy preclinical model to investigate disease pathogenesis. These 2 aims will utilize an extensive battery of in vivo assays including gait analysis, loading monitoring, joint mechanics, ultrasound imaging, and metabolomics to maximize research translation from our exciting Research Projects to clinical populations. In Aim 3, we will develop novel techniques to translate preclinical findings to improve patient care. These translational tools are necessary for follow-up animal experiments and clinical trials that will test the effectiveness of personalized rehabilitative care at improving tendon healing and outcomes while addressing existing inequitable care delivery for patients with Achilles tendon injuries. We will accelerate fundamental discovery research and translation through preclinical studies to clinical populations. By establishing the Achilles Tendinopathy Tissue Core, we will provide unique and rigorous techniques and expertise, as well as carefully controlled and characterized study material to tendon researchers locally, and ultimately nationally, while developing critical new technologies to improve patient care in future clinical research. We selected Achilles tendinopathy to address a common and debilitating condition while demonstrating the proof-of-concept model paradigm that leveraging patient tissues with preclinical models will accelerate fundamental discovery to more effective and equitable musculoskeletal care.

研究核心总结